Key result
Coexisting anxiety and depression linked to ~71% higher stage 2 hypertension risk in young adults.
Why the study?
Previous studies showed inconsistent results regarding the association between depressive symptoms and hypertension, and the impact of coexisting anxiety requires exploration.
Does the presence of self-reported anxiety and depressive symptoms increase the risk of incident hypertension in young adults?
Cohort (n=2,448)
Does the presence of self-reported anxiety and depressive symptoms increase the risk of incident hypertension in young adults?
The coexistence of self-reported anxiety and depressive symptoms significantly increases the risk of developing stage 2 hypertension in young adults.
Higher BSRS-5 scores were associated with incident hypertension in military personnel; leaves open whether mood screening or intervention modifies risk.
Aims Previous studies have revealed inconsistent results regarding the association between depressive symptoms and hypertension. Other mood disorders, such as anxiety, usually coexist with depression and require exploration of their impact on depression in patients with hypertension. Methods and results This study included 2,448 Taiwanese military personnel who were free of hypertension at baseline. Mood status was assessed using the Brief Symptoms Rating Scale-5 (BSRS-5) score, which includes five domains of depressive symptoms, anxiety, interpersonal sensitivity, insomnia, and hostility, which were evaluated separately using a five-point Likert-type scale of 0–4. Incident hypertension was defined according to the latest American guidelines, and follow-up was conducted from 2014 until the end of 2020. Multivariable Cox regression analysis was used to determine the associations of each mood item and a combination of the significant items with incident hypertension, with adjustments for potential confounders. Results There were 125 new-onset stage 2 hypertension cases (5.2%) during a median follow-up period of 6.0 years. The sum of the BSRS-5 scores was not linked to new-onset stage 2 hypertension [hazard ratio (HR) and 95% confidence interval (CI): 1.05 (0.99–1.11)]. Among the five mood domains, depressive symptoms (score ≥1) were significantly associated with new-onset stage 2 hypertension [HR 1.68 (95% CI 1.16–2.45)], whereas anxiety symptoms (score ≥1) showed a borderline association [HR 1.43 (95% CI 0.99–2.08)]. Neither of the associations was linear. The presence of depressive symptoms alone or anxiety symptoms alone (one score ≥1 and another score = 0) was not associated with stage 2 hypertension (HR: 1.11, p = 0.71), whereas both scores ≥1 were associated with a higher risk of stage 2 hypertension [HR: 1.71 (95% CI 1.14–2.57)]. Conclusions Our findings suggest that the coexistence of self-reported anxiety and depressive symptoms may increase the risk of stage 2 hypertension in young military adults.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) conducted a cohort in Incident hypertension (n=2,448). Coexisting anxiety and depressive symptoms vs. No anxiety or depressive symptoms was evaluated on Incident stage 2 hypertension (HR 1.71, 95% CI 1.14-2.57, p=0.009). The coexistence of self-reported anxiety and depressive symptoms significantly increased the risk of incident stage 2 hypertension (HR 1.71) in young adults compared to having neither symptom.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: